Novel Non-Pharmaceutical Advancements in Heart Failure Management: The Emerging Role of Technology

Link to article at PubMed

Curr Cardiol Rev. 2021 Aug 31. doi: 10.2174/1573403X17666210831144141. Online ahead of print.


PURPOSE OF REVIEW: To summarise and discuss the implications of recent technological advances in heart failure care.

RECENT FINDINGS: Heart failure remains a significant source of morbidity and mortality in the US population despite multiple classes of approved pharmacological treatments. Novel cardiac devices and technologies may offer an opportunity to improve outcomes. Baroreflex Activation Therapy and Cardiac Contractility Remodelling may improve myocardial contractility by altering neurohormonal stimulation of the heart. Implantable Pulmonary Artery Monitors and Biatrial Shunts may prevent heart failure admissions by altering the trajectory of progressive congestion. Phrenic Nerve Stimulation offers potentially effective treatment for comorbid conditions. Smartphone applications offer an intriguing strategy for improving medication adherence.

SUMMARY: Novel heart failure technologies offer promise for reducing this public health burden. Randomized controlled studies are indicated for assessing the future role of these novel therapies.

PMID:34488615 | DOI:10.2174/1573403X17666210831144141

Leave a Reply

Your email address will not be published.